NCT02697617View on ClinicalTrials.gov

Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 26, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

January 31, 2020

Conditions
Polycystic Kidney Disease
Interventions
DRUG

Pioglitazone

Pioglitazone

DRUG

Placebo

Placebo

Trial Locations (1)

46202

Indiana University Health, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT02697617 - Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease | Biotech Hunter | Biotech Hunter